TY  - GEN
AU  - Berenson,James R
AU  - Boccia,Ralph
AU  - Siegel,David
AU  - Bozdech,Marek
AU  - Bessudo,Alberto
AU  - Stadtmauer,Edward
AU  - Talisman Pomeroy,J
AU  - Steis,Ronald
AU  - Flam,Marshall
AU  - Lutzky,Jose
AU  - Jilani,Syed
AU  - Volk,Joseph
AU  - Wong,Siu-Fun
AU  - Moss,Robert
AU  - Patel,Ravi
AU  - Ferretti,Delina
AU  - Russell,Kit
AU  - Louie,Robert
AU  - Yeh,Howard S
AU  - Swift,Regina A
TI  - Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study
SN  - 0007-1048
PY  - 2006///1108
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Arsenic Trioxide
KW  - Arsenicals
KW  - administration & dosage
KW  - Ascorbic Acid
KW  - Creatinine
KW  - blood
KW  - Female
KW  - Humans
KW  - Male
KW  - Melphalan
KW  - Middle Aged
KW  - Multiple Myeloma
KW  - Oxides
KW  - Prospective Studies
KW  - Recurrence
KW  - Survival Analysis
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1365-2141.2006.06280.x
ER  -